Refresh

DR.REDDY'S LABORATORIES LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release


Download
05 Jun 2023
Dr. Reddy's successfully completes Phase I study (IV route) of DRL_TC, a proposed biosimilar of tocilizumab

Source: BSE India

View all announcements for DR.REDDY'S LABORATORIES LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com